Research programme: diabetes therapy - Abbott/Metabolex
Alternative Names: Diabetes therapy research programme - Abbott/MetabolexLatest Information Update: 25 Jan 2013
At a glance
- Originator Abbott Laboratories; Metabolex
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 09 Aug 2007 Discontinued - Preclinical for Diabetes mellitus in USA (unspecified route)
- 06 Aug 2003 No development reported - Preclinical for Diabetes mellitus in USA (unspecified route)
- 27 Jul 2000 Preclinical development for Diabetes mellitus in USA (Unknown route)